Adrenergic transmission properties and implication
肾上腺素能传输特性及意义
基本信息
- 批准号:10637114
- 负责人:
- 金额:$ 40.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Adrenergic AgentsAdrenergic ReceptorAlgorithmic AnalysisAlzheimer&aposs DiseaseArousalAttentionAttentional deficitBehaviorBiological ProcessBrainCardiovascular DiseasesCell NucleusCentral Nervous SystemClinicalCognitionComplexCouplingDataDepressive disorderDiffusionEngineeringEpinephrineEventFamilyFutureG-Protein-Coupled ReceptorsGoldGreen Fluorescent ProteinsHealthHeartHumanImage AnalysisImmuneIndividualInvestigationLinkMental disordersMicroscopicMonitorMusNeuronsNeurotransmittersNorepinephrineOrganOutputPancreasParkinson DiseasePathologicPerformancePeripheralPeripheral Nervous SystemPhysiologicalPhysiological ProcessesPlayPontine structurePreparationProbabilityPropertyReceptor ActivationRegulationResearchResolutionRoleSchemeSchizophreniaSensorySignal TransductionSiteSleepSleep DisordersSpleenSynapsesTestingTissuesVisualizationWood materialautism spectrum disordercognitive functionexperimental studyimprovedlocus ceruleus structuremonoaminenervous system disorderneurotransmissionnovelsensortooltransmission processtumorigenesisultra high resolution
项目摘要
PROJECT SUMMARY
Norepinephrine (NE) and epinephrine (Epi) have been implicated in complex cognitive functions,
such as sensory processing, sleep-wake/arousal state transition and attention, in the brain, and other
biological processes in various tissues and organs, including the heart, pancreas and spleen.
Dysregulation of adrenergic transmission is linked to a number of neurological diseases, including
Alzheimer’s disease, depressive disorders and schizophrenia, as well as many other health problems,
including cardiovascular diseases, immune-deficiency and tumorigenesis.
Despite the potential involvement of NE/Epi in myriad physiological and pathological conditions,
the precise regulation and exact functional role of adrenergic transmission remain poorly defined, due
primarily to limitations of available tools for monitoring NE/Epi. We have recently developed a family
of intensity-based G-protein-coupled receptor (GPCR) activation-based genetically encoded NE
(GRABNE) sensors by coupling a circular permutated green fluorescent protein (cpGFP) with a human
adrenergic receptor. While these GRABNE sensors allowed the first visualization of adrenergic
transmission, the sensors were suboptimal in determining synaptic properties of adrenergic
transmission. To facilitate NE/Epi research, we recently engineered high-performance GRABNE
sensors that allowed high-sensitivity and high-resolution visualization of adrenergic transmission events
at single release sites. The new sensors and preliminary data build up our confidence to test the
hypothesis that high-performance GRABNE sensors may resolve the adrenergic transmission
properties that could deduce the adrenergic functional role. This application follows two specific
aims: Aim 1 is to determine whether high-performance GRABNE sensors may resolve adrenergic
transmission properties, and Aim 2 is to test whether adrenergic transmission plays an essential role in
the precision- and attention-demanding behaviors. We expect the proposed experiments to
characterize the first set of fundamental synaptic properties of a new form of neuronal transmission and
define a novel, unique functional role for adrenergic transmission.
项目总结
去甲肾上腺素(NE)和肾上腺素(Epi)与复杂的认知功能有关,
例如感觉处理、睡眠-觉醒/觉醒状态转换和注意力
在各种组织和器官中的生物过程,包括心脏、胰腺和脾。
肾上腺素能传递的失调与许多神经系统疾病有关,包括
阿尔茨海默氏症、抑郁障碍和精神分裂症,以及许多其他健康问题,
包括心血管疾病、免疫缺陷和肿瘤发生。
尽管NE/Epi可能参与多种生理和病理情况,
肾上腺素能传递的精确调节和确切的功能作用仍然不清楚,因为
主要是由于可用于监测NE/EPI的工具的局限性。我们最近发展了一个家庭
基于强度的G蛋白偶联受体(GPCR)激活基于遗传编码的NE
环状置换绿色荧光蛋白(CpGFP)与人
肾上腺素能受体。当这些GRABNE传感器允许首次看到肾上腺素能
传输,传感器在确定肾上腺素能突触特性方面是次优的。
变速箱。为了促进NE/EPI的研究,我们最近设计了高性能的GRABNE
允许高灵敏度和高分辨率可视化肾上腺素能传递事件的传感器
在单一的释放地点。新的传感器和初步数据增强了我们测试
高性能GRABNE传感器可能解决肾上腺素能传递的假说
可以推断肾上腺素能功能作用的性质。此应用程序遵循两个特定的
目的:目的1是确定高性能的GRABNE传感器是否可以分解肾上腺素能
传递特性,目标2是测试肾上腺素能传递是否在
要求精确度和注意力的行为。我们预计拟议中的实验将
描述一种新形式的神经元传递的第一组基本突触属性和
为肾上腺素能传递定义一个新的、独特的功能角色。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Beenhakker其他文献
Mark Beenhakker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Beenhakker', 18)}}的其他基金
Architectonic analysis of complex cortical circuits in healthy and diseased brain
健康和患病大脑中复杂皮质回路的结构分析
- 批准号:
10749697 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced excitation and epilepsy with chloride channel dysfunction
氯离子通道功能障碍导致兴奋增强和癫痫
- 批准号:
8385715 - 财政年份:2011
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced excitation and epilepsy with chloride channel dysfunction
氯离子通道功能障碍导致兴奋增强和癫痫
- 批准号:
8396375 - 财政年份:2011
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced excitation and epilepsy with chloride channel dysfunction
氯离子通道功能障碍导致兴奋增强和癫痫
- 批准号:
8586278 - 财政年份:2011
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced excitation and epilepsy with chloride channel dysfunction
氯离子通道功能障碍导致兴奋增强和癫痫
- 批准号:
7642720 - 财政年份:2009
- 资助金额:
$ 40.38万 - 项目类别:
Motor Pattern Selection From a Multifunctional Network
从多功能网络选择电机模式
- 批准号:
6606962 - 财政年份:2002
- 资助金额:
$ 40.38万 - 项目类别:
Motor Pattern Selection From a Multifunctional Network
从多功能网络选择电机模式
- 批准号:
6540499 - 财政年份:2002
- 资助金额:
$ 40.38万 - 项目类别:
Motor Pattern Selection From a Multifunctional Network
从多功能网络选择电机模式
- 批准号:
6339651 - 财政年份:2001
- 资助金额:
$ 40.38万 - 项目类别:
相似海外基金
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
- 批准号:
RGPIN-2019-04706 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
- 批准号:
22K07118 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




